tolvaptan has been researched along with Cardiomyopathy, Hypertrophic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kajimoto, K; Otsubo, S | 1 |
1 other study(ies) available for tolvaptan and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Adding High-Dose Spironolactone to Tolvaptan Improves Acute Decompensated Heart Failure Due to Obstructive Hypertrophic Cardiomyopathy and Aortic Stenosis: A Case Report.
Topics: Acute Disease; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Aortic Valve Stenosis; Cardiomyopathy, Hypertrophic; Drug Therapy, Combination; Dyspnea; Female; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Spironolactone; Tolvaptan | 2019 |